Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 300, Issue 4, 2011, Pages

  Hirooka, Yoshitaka ^a   Kishi, Takuya ^a   Sakai, Koji ^a   Takeshita, Akira ^a   Sunagawa, Kenji ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Blood pressure; Central nervous system; Nitric oxide; Oxidative stress; Sympathetic nervous system

Indexed keywords

4 AMINOBUTYRIC ACID; ANGIOTENSIN 1 RECEPTOR; ANTIHYPERTENSIVE AGENT; ATORVASTATIN; CALCIUM CHANNEL BLOCKING AGENT; CYCLIC AMP; DIHYDROPYRIDINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NEURONAL NITRIC OXIDE SYNTHASE; NEUROTRANSMITTER; NITRIC OXIDE; OLMESARTAN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; ROSIGLITAZONE; TELMISARTAN;

4 AMINOBUTYRIC ACID RELEASE; ADRENERGIC SYSTEM; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; BRAIN STEM; CENTRAL NERVOUS SYSTEM; HYPERTENSION; NEUROTRANSMITTER RELEASE; NONHUMAN; OXIDATIVE STRESS; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SYMPATHETIC TONE;

ANIMALS; BRAIN STEM; HUMANS; HYPERTENSION; MODELS, ANIMAL; NEUROTRANSMITTER AGENTS; NITRIC OXIDE; RATS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SYMPATHETIC NERVOUS SYSTEM;

EID: 79954995867     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00426.2010     Document Type: Review

References (136)

1. Alaghband-Zadeh J, Das I, Hanson MR, MacGregor CAL, de Wardener HE, Laycock JF. Hypothalamic and plasma total nitrate/nitrite concentrations in spontaneously hypertensive rats. Exp Physiol 81: 881-883, 1996.
2. Allen AM, O'Callaghan EL, Chen D, Bassi JK. Central neural regulation of cardiovascular function by angiotensin: a focus on the rostral ventrolateral medulla. Neuroendocrinology 89: 361-369, 2009.
3. Anzai K, Saito K, Takeshita K, Takahashi S, Miyazaki H, Shoji H, Lee MC, Masumizu T, Ozawa T. Assessment of ESR-CT imaging by comparison with autoradiography for the distribution of a blood-brainbarrier permeable spin probe, MC-PROXYL, to rodent brain. Magn Reson Imaging 21: 765-772, 2003.
4. Araki S, Hirooka Y, Kishi T, Yasukawa K, Utsumi H, Sunagawa K. Olmesartan reduces oxidative stress in the brain of stroke-prone spontaneously hypertensive rats assessed by an in vivo ESR method. Hypertens Res 32: 1091-1096, 2009.
5. Bai Y, Jabbari B, Ye S, Campese VM. Regional expression of NAD(P)H oxidase and superoxide dismutase in the brain of rats with neurogenic hypertension. Am J Nephrol 29: 483-492, 2009.
6. Bains JS, Ferguson AV. Nitric oxide depolarizes type II paraventricular nucleus neurons in vitro. Neuroscience 79: 149-159, 1997.
7. Bains JS, Ferguson AV. Nitric oxide regulates NMDA-drived GABAergic inputs to type I neurons of the rat paraventricular nucleus. J Physiol 499: 733-746, 1997.
8. Batten TFC, Atkinson L, Deuchars J. Nitric oxide systems in the medulla oblongata and their involvement in autonomic control. In: Functional Neuroanatomy of the Nitric Oxide System. Handbook of Chemical Neuroanatomy, edited by Steinbusch HWM, De Vente J, Vincent SR, Amsterdam, The Netherlands: Elsevier, 177-213, 2000.
9. Bergamaschi CT, Campos RR, Lopes OU. Rostral ventrolateral medulla: a source of sympathetic activation in rats subjected to long-term treatment with L-NAME. Hypertension 34: 744-747, 1999.
10. Bourassa EA, Sved AF, Speth RC. Angiotensin modulation of rostral ventrolateral medulla (RVLM) in cardiovascular regulation. Mol Cell Endocrinol 302: 167-175, 2009.
11. Brandes RP. Vascular functions of NADPH oxidases. Hypertension 56: 17-21, 2010.
12. Briones AM, Touyz RM. Oxidative stress and hypertension: current concepts. Curr Hypertens Rep 12: 135-142, 2010.
13. Cabrena CL, Bealer SL, Bohr DF. Central depressor action of nitric oxide is deficient in genetic hypertension. Am J Hypertens 9: 237-241, 1996.
14. Campese VM, Sindhu RK, Ye S, Bai Y, Vaziri ND, Jabbari B. Regional expression of NO synthase, NAD(P)H oxidase and superoxide dismutase in the rat brain. Brain Res 1134: 27-32, 2007.
15. Campese VM, Shaohua Y, Huiquin Z. Oxidative stress mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension 46: 533-539, 2005.
16. Campos RR, Bergamaschi CT. Neurotransmission alterations in central cardiovascular control in experimental hypertension. Curr Hypertens Rev 2: 193-198, 2006.
17. Campos RR. Oxidative stress in the brain and arterial hypertension. Hypertens Res 32: 1047-1048, 2009.
18. Chan SHH, Hsu KS, Huang CC, Wang LL, Ou CC, Chan JYH. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced pressor effect via activation of p38 mitogen-activated protein kinase in the rostral ventrolateral medulla. Circ Res 97: 772-780, 2005.
19. Chan SHH, Tai MH, Li CY, Chan JYH. Reduction in molecular synthesis or enzyme activity of superoxide dismutase and catalase contributes to oxidative stress and neurogenic hypertension in spontaneously hypertensive rats. Free Radic Biol Med 40: 2028-2039, 2006.
20. 1 receptor gene on activation of protein kinase Cβ/nicotinamide adenine dinucleotide diphosphate oxidase/ERK1/2/c-fos signaling cascade mediates long-term pressor effect of angiotensin II in rostral ventrolateral medulla. J Hypertens 25: 1845-1861, 2007.
21. Chan SHH, Wu KLH, Chang AYW, Tai MH, Chan JYH. Oxidative impairment of mitochondrial electron transport chain complexes in rostral ventrolateral medulla contributes to neurogenic hypertension. Hypertension 53: 217-227, 2009.
22. Chan SHH, Wu CA, Wu KLH, Ho YH, Chang AYW, Chang JYH. Transcriptional upregulation of mitochondrial uncoupling protein 2 protects against oxidative stress-associated neurogenic hypertension. Circ Res 105: 886-896, 2009.
23. Chan SHH, Wu KLH, Kung PSS, Chan JYH. Oral intake of rosiglitazone promotes a central antihypertensive effect via upregulation of peroxisome proliferator-activated receptor-and alleviation of oxidative stress in rostral ventrolateral medulla of spontaneously hypertensive rats. Hypertension 55: 1444-1453, 2010.
24. 1-receptor blockers. J Hum Hypertens 16: S64-S70, 2002.
25. Dampney RAL. Functional organization of central pathways regulating the cardiovascular system. Physiol Rev 74: 323-364, 1994.
26. Dampney RAL, Fontes MAP, Hirooka Y, Potts PD, Tagawa T. Role of angiotensin II receptors in the regulation of vasomotor neurons in the rostral ventrolateral medulla. Clin Exp Pharmacol Physiol 29: 467-472, 2002.
27. Dias AC, Vitela M, Colombari E, Mifflin SW. Nitric oxide modulation of glutamatergic, baroreflex, and cardiopulmonary transmission in the nucleus of the solitary tract. Am J Physiol Heart Circ Physiol 288: H256-H262, 2005.
28. Dupont AG, Brouwers S. Brain angiotensin peptides regulate sympathetic tone and blood pressure. J Hypertens 28: 1599-1610, 2010.
29. Eshima K, Hirooka Y, Shigematsu H, Matsuo I, Koike G, Sakai K, Takeshita A. Angiotensin in the nucleus tractus solitarii contributes to neurogenic hypertension caused by chronic nitric oxide synthase inhibition. Hypertension 36: 259-263, 2000.
30. Esler M. Sympathetic nervous activation in essential hypertension: commonly neglected as a therapeutic target, usually ignored as a drug side effect. Hypertension 55: 1090-1091, 2010.
31. Esler M. The 2009 Carl Ludwig Lecture. Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the translation from mechanisms to medical management. J Appl Physiol 108: 227-237, 2010.
32. Garthwaite J. Concepts of neural nitric oxide-mediated transmission. Eur J Neurosci 27: 2783-2802, 2008.
33. Girouard H, Wang G, Gallo EF, Anthrather J, Zhou P, Pickel VM, Iadecola C. NMDA receptor activation increases free radical production through nitric oxide and Nox2. J Neurosci 29: 2545-2552, 2009.
34. Gohlke P, Weiss S, Jansen A, Wienen W, Stangier J, Rascher W, Culman J, Unger T. AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious rats. J Pharmacol Exp Ther 298: 62-70, 2001.
35. Grassi G. Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension 54: 690-697, 2009.
36. Grassi G. Sympathetic neural activity in hypertension and related diseases. Am J Hypertens 23: 1052-1060, 2010.
37. Grassi G, Seravalle G, Quarti-Trevano F. The 'neurogenic hypothesis' in hypertension: current evidence. Exp Physiol 95: 581-586, 2010.
38. Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci 7: 335-346, 2006.
39. Harada S, Tokunaga S, Momohara M, Masaki H, Tagawa T, Imaizumi T, Takeshita A. Inhibition of nitric oxide formation in the nucleus tractus solitarius increases renal sympathetic nerve activity in rabbits. Circ Res 72: 511-516, 1993.
40. Haüser W, Sassmann A, Qadri F, Jöhren O, Dominiak P. Expression of nitric oxide synthase isoforms in hypothalamo-pitutary-adrenal axis during the development of spontaneously hypertension in rats. Mol Brain Res 138: 198-204, 2005.
41. Hironaga K, Hirooka Y, Matsuo I, Shihara M, Tagawa T, Harasawa Y, Takeshita A. Role of endogenous nitric oxide in the brain stem on the rapid adaptation of baroreflex. Hypertension 31: 27-31, 1998.
42. Hirooka Y, Polson JW, Dampney RAL. Pressor and sympathoexcitatory effects of nitric oxide in the rostral ventrolateral medulla. J Hypertens 14: 1317-1324, 1996.
43. Hirooka Y, Kishi T, Sakai K, Shimokawa H, Takeshita A. Effect of overproduction of nitric oxide in the brain stem on the cardiovascular response in conscious rats. J Cardiovasc Pharmacol 41 Suppl 1: S119-S126, 2003.
44. Hirooka Y, Sakai K, Kishi T, Ito K, Shimokawa H, Takeshita A. Enhanced depressor response to endothelial nitric oxide synthase gene transfer into the nucleus tractus solitarii of spontaneously hypertensive rats. Hypertens Res 26: 325-331, 2003.
45. Hirooka Y, Kimura Y, Nozoe M, Sagara Y, Ito K, Sunagawa K. Amlodipine-induced reduction of oxidative stress in the brain is associated with sympatho-inhibitory effects in stroke-prone spontaneously hypertensive rats. Hypertens Res 29: 49-56, 2006.
46. Hirooka Y. Localized gene transfer and its application for the study of central cardiovascular control. Auton Neurosci 126-127: 120-129, 2006.
47. Hirooka Y. Role of reactive oxygen species in brainstem in neural mechanisms of hypertension. Auton Neurosci 142: 20-24, 2008.
48. Hirooka Y, Sagara Y, Kishi T, Sunagawa K. Oxidative stress and central cardiovascular regulation: pathogenesis of hypertension and therapeutic aspects. Circ J 74: 827-835, 2010.
49. Horn T, Smith PM, McLaughlin BE, Bauce L, Marks GS, Pittman QJ, Ferguson AV. Nitric oxide actions in paraventricular nucleus: cardiovascular and neurochemical implications. Am J Physiol Regul Integr Comp Physiol 266: R306-R313, 1994.
50. Inaba S, Iwai M, Furuno M, Tomono Y, Senba I, Okayama H, Mogi M, Higaki J, Horiuchi M. Continuous activation of renin-angiotensin system impairs cognitive function in renin/angiotensinogen transgenic mice. Hypertension 53: 356-362, 2009.
51. Infanger DW, Shrama RV, Davisson RL. NADPH oxidases of the brain: distribution, regulation, and function. Antioxid Redox Signal 8: 1583-1596, 2006.
52. Judy WV, Watanabe AM, Henry DP, Besch HR, Murphy WR, Hockel GM. Sympathetic nerve activity: role in regulation of blood pressure in the spontaneously hypertensive rat. Circ Res 38: I-121-I-129, 1976.
53. Kagiyama S, Tsuchihashi T, Abe I, Fujishima M. Cardiovascular effects of nitric oxide in the rostral ventrolateral medulla of rats. Brain Res 757: 155-158, 1997.
54. Kimura Y, Hirooka Y, Sagara Y, Ito K, Kishi T, Shimokawa H, Takeshita A, Sunagawa K. Overexpression of inducible nitric oxide synthase in rostral ventrolateral medulla causes hypertension and sym-pathoexcitation via an increase in oxidative stress. Circ Res 96: 252-260, 2005.
55. Kimura Y, Hirooka Y, Sagara Y, Sunagawa K. Long-acting calcium channel blocker, azelnidipine, increases endothelial nitric oxide synthase in the brain and inhibits sympathetic nerve activity. Clin Exp Hypertens 29: 13-21, 2007.
56. Kimura Y, Hirooka Y, Kishi T, Ito K, Sagara Y, Sunagawa K. Role of inducible nitric oxide synthase in rostral ventrolateral medulla in blood pressure regulation in spontaneously hypertensive rats. Clin Exp Hypertens 31: 281-286, 2009.
57. Kishi T, Hirooka Y, Shigematsu H, Shimokawa H, Takeshita A. Overexpression of eNOS in the RVLM causes hypotension and bradycardia via GABA release. Hypertension 38: 896-901, 2001.
58. Kishi T, Hirooka Y, Ito K, Sakai K, Shimokawa H, Takeshita A. Cardiovascular effects of overexpression of endothelial nitric oxide synthase in the rostral ventrolateral medulla in stroke-prone spontaneously hypertensive rats. Hypertension 39: 264-268, 2002.
59. Kishi T, Hirooka Y, Mukai Y, Shimokawa H, Takeshita A. Atorvastatin causes depressor and sympatho-inhibitory effect with upregulation of nitric oxide synthases in stroke-prone hypertensive rats. J Hypertens 21: 379-386, 2003.
60. Kishi T, Hirooka Y, Kimura Y, Sakai K, Ito K, Shimokawa H, Takeshita A. Overexpression of eNOS in RVLM improves impaired baroreflex control of heart rate in SHRSP. Hypertension 41: 255-260, 2003.
61. Kishi T, Hirooka Y, Kimura Y, Ito K, Shimokawa H, Takeshita A. Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation 109: 2357-2362, 2004.
62. Kishi T, Hirooka Y, Shimokawa H, Takeshita A, Sunagawa K. Atorvastatin reduces oxidative stress in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats. Clin Exp Hypertens 30: 3-11, 2008.
63. Kishi T, Hirooka Y, Konno S, Sunagawa K. Atorvastatin improves the impaired baroreflex sensitivity via anti-oxidant effect in the rostral ventrolateral medulla of SHRSP. Clin Exp Hypertens 31: 698-704, 2009.
64. Kishi T, Hirooka Y, Konno S, Sunagawa K. Sympathoinhibition induced by centrally administered atorvastatin is associated with alteration of NAD(P)H and Mn-SOD activity in rostral ventrolateral medulla of stroke-prone SHR. J Cardiovasc Pharmacol 55: 184-190, 2010.
65. Kishi T, Hirooka Y, Konno S, Ogawa K, Sunagawa K. Angiotensin type 1 receptor-activated caspase-3 through ras/mitogen-activated protein kinase/extracellular signal-regulated kinase in the rostral ventrolateral medulla is involved in sympathoexcitation in stroke-prone spontaneously hypertensive rats. Hypertension 55: 291-297, 2010.
66. Koga Y, Hirooka Y, Araki S, Nozoe M, Kishi T, Sunagawa K. High salt intake enhances blood pressure increase during development of hypertension via oxidative stress in rostral ventrolateral medulla of spontaneously hypertensive rats. Hypertens Res 31: 2075-2083, 2008.
67. Konno S, Hirooka Y, Araki S, Koga Y, Kishi T, Sunagawa K. Azelnidipine decreases sympathetic nerve activity via antioxidant effect in the rostral ventrolateral medulla of stoke-prone spontaneously hypertensive rats. J Cardiovasc Pharmacol 52: 555-560, 2008.
68. Kung LC, Chan SHH, Wu KLH, Ou CC, Tai MH, Chan JYH. Mitochondrial respiratory enzyme complexes in rostral ventrolateral medulla as cellular targets of nitric oxide and superoxide interaction in the antagonism of antihypertensive action of eNOS transgene. Mol Pharmacol 74: 1319-1332, 2008.
69. Kurukoff TL, Gehlen F, Ganten D, Wagner J. Gene expression of brain nitric oxide synthase and soluble guanylate cyclase in hypothalamus and medulla of two-kidney, one-clip hypertensive rats. Hypertension 26: 171-176, 1995.
70. Krukoff TL. Central action of nitric oxide in regulation of autonomic functions. Brain Res Rev 30: 52-65, 1999.
71. Lambeth JD. Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy. Free Radic Biol Med 43: 332-347, 2007.
72. Lassegue B, Clempus RE. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285: R277-R297, 2003.
73. Leenen FHH, Ruzicka M, Huang BS. Central sympathoinhibitory effects of calcium channel blockers. Curr Hypertens Res 3: 314-321, 2001.
74. Lin HC, Kang BH, Wan FJ, Huang ST, Tseng CJ. Reciprocal regulation of nitric oxide and glutamate in the nucleus tractus solitarii of rats. Eur J Pharmacol 407: 83-89, 2000.
75. Lin LH. Glutamatergic neurons say NO in the nucleus tractus solitarii. J Chem Neuroanat 38: 1154-165, 2009.
76. Lin Y, Matsumura K, Kagiyama S, Fukuhara M, Fujii K, Iida M. Chronic administration of olmesartan attenuates the exaggerated pressor response to glutamate in the rostral ventrolateral medulla of SHR. Brain Res 1058: 161-166, 2005.
77. Liu D, Gao L, Roy SK, Cornish KG, Zucker IH. Neuronal angiotensin II type 1 receptor upregulation in heart failure: activation of activator protein 1 and jun N-terminal kinase. Circ Res 99: 1004-1011, 2006.
78. Liu JL, Murakami H, Zucker IH. Effects of NO on baroreflex control of heart rate and renal nerve activity in conscious rabbits. Am J Physiol Regul Integr Comp Physiol 270: R1361-R1370, 1996.
79. Luft FC, Demmert G, Rohmeiss P, Unger T. Baroreceptor reflex effect on sympathetic nerve activity in stroke-prone spontaneously hypertensive rats. J Auton Nerv Syst 17: 199-209, 1986.
80. Ma S, Abboud FM, Felder RB. Effects of L-arginine-derived nitric oxide synthesis on neuronal activity in nucleus tractus solitarius. Am J Physiol Regul Integr Comp Physiol 268: R487-R491, 1995.
81. Marting-Pinge MC, Baraldi-Passy I, Lopes OU. Excitatory effects of nitric oxide within the rostral ventrolateral medulla of freely moving rats. Hypertension 30: 704-707, 1997.
82. Matsuo I, Hirooka Y, Hironaga K, Eshima K, Shigematsu H, Shihara M, Sakai K, Takeshita A. Glutamate release via NO production evoked by NMDA in the NTS enhances hypotension and bradycardia in vivo. Am J Physiol Regul Integr Comp Physiol 280: R1285-R1291, 2001.
83. McKinley MJ, Albinson AL, Allen AM, Mathai M, May CN, Mc-Allen RM, Oldfield BJ, Mendelsohn FAO, Chai SY. The brain reninangiotensin system: location and physiological roles. Int J Biochem Cell Biol 35: 901-918, 2003.
84. Mogi M, Horiuchi M. Remote control of brain angiotensin II levels by angiotensin receptor blockers. Hypertens Res 33: 116-117, 2010.
85. Morimoto S, Cassel MD, Beltz TG, Johnson AK, Davisson RL, Sigmund CD. Elevated blood pressure in transgenic mice with brainspecific expression of human angiotensinogen driven by the glial fibrillary acidic protein promoter. Circ Res 89: 365-372, 2001.
86. Morimoto S, Cassell MD, Sigmund CD. The brain renin-angiotensin system in transgenic mice carrying a highly regulated human renin transgene. Circ Res 90: 80-86, 2002.
87. Murakami H, Liu JL, Yoneyama H, Nishida Y, Okada K, Kosaka H, Morita H, Zucker IH. Blockade of neuronal nitric oxide synthase alters the baroreflex control of heart rate in the rabbit. Am J Physiol Regul Integr Comp Physiol 274: R181-R186, 1998.
88. Murphy S, Gibson CL. Nitric oxide, ischaemia and brain inflammation. Biochem Soc Trans 35: 1133-1137, 2007.
89. 1 receptors. Brain Res 871: 29-38, 2000.
90. Nozoe M, Hirooka Y, Koga Y, Sagara Y, Kishi T, Engelhardt JF, Sunagawa K. Inhibition of rac1-derived reactive oxygen species in nucleus tractus solitarius decreases blood pressure and heart rate in stroke-prone spontaneously hypertensive rats. Hypertension 50: 62-68, 2007.
91. Nozoe M, Hirooka Y, Koga Y, Araki S, Konno S, Kishi T, Ide T, Sunagawa K. Mitochondria-derived reactive oxygen species mediate sympathoexcitation induced by angiotensin II in the rostral ventrolateral medulla. J Hypertens 26: 2176-2184, 2008.
92. Oliveira-Sales EB, Dugaich AP, Carillo BA, Abreu NP, Boim MA, Martins PJ, D'Almeida V, Dolnkoff MS, Bergamaschi CT, Campos RR. Oxidative stress contributes to renovascular hypertension. Am J Hypertens 21: 98-104, 2008.
93. Oliveira-Sales EB, Nishi EE, Carillo BA, Dolnikoff MS, Bergamaschi CT, Campos RR. Oxidative stress in the sympathetic premotor neurons contributes to sympathetic activation in renovascular hypertension. Am J Hypertens 22: 484-492, 2009.
94. Paravicini T, Touyz RM. Redox signaling in hypertension. Cardiovasc Res 71: 247-258, 2006.
95. Patel KP, Li YF, Hirooka Y. Role of nitric oxide in central sympathetic outflow. Exp Biol Med (Maywood) 226: 814-824, 2001.
96. Paton JFR, Waki H, Abdala APL, Dickinson J, Kasparov S. Vascular-brain signaling in hypertension: role of angiotensin II and nitric oxide. Curr Hypertens Rep 9: 242-247, 2007.
97. Pannu R, Singh I. Pharmacological strategies for the regulation of inducible nitric oxide synthase: neurogenerative versus neuroprotective mechanisms. Neurochem Intl 49: 170-182, 2006.
98. Pelisch N, Hosomi N, Ueno M, Masugata H, Murao K, Hitomi H, Nakao D, Kobori H, Nishiyama A, Kohno M. Systemic candesartan reduces brain angiotensin II via downregulation of brain renin-angiotensin system. Hypertens Res 33: 161-164, 2010.
99. Peterson JR, Shrama RV, Davisson RL. Reactive oxygen species in the neuropathogenesis of hypertension. Curr Hypertens Rep 8: 232-241, 2006.
100. Pilowsky P, Goodchild AK. Baroreceptor reflex pathways and neurotransmitters: 10 years on. J Hypertens 20: 1675-1688, 2002.
101. Plochocka-Zulinska D, Krukoff TL. Increased gene expression of neuronal nitric oxide synthase in brain of adult spontaneously hypertensive rats. Mol Brain Res 48: 291-297, 1997.
102. Polizio AH, Peña C. Effects of angiotensin II type 1 receptor blockade on the oxidative stress in spontaneously hypertensive rat tissues. Regul Pept 128: 1-5, 2005.
103. Pontieri V, Venezuela MK, Scavone C, Michelini LC. Role of endogenous nitric oxide in the nucleus tractus solitarii on baroreflex control of heart rate in spontaneously hypertensive rats. J Hypertens 16: 1993-1999, 1998.
104. Qadri F, Arens T, Schwarz EC, Häuser W, Dendorfer A, Dominiak P. Brain nitric oxide synthase activity in spontaneously hypertensive rats during development of hypertension. J Hypertens 21: 1687-1694, 2003.
105. 1 receptor and intracellular kinase gene expression in hypertensive rats. Clin Exp Pharmacol Physiol 33: 690-695, 2006.
106. Ren J. Influence of gender on oxidative stress, lipid peroxidation, protein damage and apoptosis in hearts and brains from spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 34: 432-438, 2007.
107. Sakai K, Hirooka Y, Matsuo I, Eshima K, Shigematsu H, Shimokawa H, Takeshita A. Overexpression of eNOS in NTS causes hypotension and bradycardia in vivo. Hypertension 36: 1023-1028, 2000.
108. Sakai K, Agassandian K, Morimoto S, Sinnayah P, Cassell MD, Davisson RL, Sigmund CD. Local production of angiotensin II in the subfornical organ causes elevated drinking. J Clin Invest 117: 1088-1095, 2007.
109. Sander M, Chavoshan B, Victor RG. A large blood pressure-raising effect of nitric oxide synthase inhibition in humans. Hypertension 33: 937-942, 1999.
110. Sano H, Matsumoto K, Utsumi H. Synthesis and imaging of bloodbrain-barrier permeable nitroxyl-probes for free radicals reactions in brain of living mice. Biochem Mol Biol Int 42: 641-647, 1997.
111. Sano H, Naruse M, Matsumoto K, Oi T, Utsumi H. A new nitroxyprobe with high retention in the brain and its application for brain imaging. Free Radic Biol Med 28: 959-969, 2000.
112. Shapoval LN, Sagach VF, Pobegailo LS. Nitric oxide influences ventrolateral medullary mechanisms of vasomotor control in the cat. Neurosci Lett 132: 47-50, 1991.
113. Sun C, Sellers KW, Sumners C, Raizada MK. NAD(P)H oxidase inhibition attenuates neuronal chronotropic actions of angiotensin II. Circ Res 96: 659-666, 2005.
114. Sun J, Druhan LJ, Zweier JL. Reactive oxygen and nitrogen species regulate inducible nitric oxide synthase function shifting the balance of nitric oxide and superoxide production. Arch Biochem Biophys 494: 130-137, 2010.
115. Sved AF, Ito S, Sved JC. Brainstem mechanisms of hypertension: role of the rostral ventrolateral medulla. Curr Hypertens Rep 5: 262-268, 2003.
116. Tagawa T, Imaizumi T, Harada S, Endo T, Shiramoto M, Hirooka Y, Takeshita A. Nitric oxide influences neuronal activity in the nucleus tractus solitarius of rat brainstem slices. Circ Res 75: 70-76, 1994.
117. Tai MH, Wang LL, Wu KLH, Chan JYH. Increased superoxide anion in rostral ventrolateral medulla contributes to hypertension in spontaneously hypertensive rats via interactions with nitric oxide. Free Radic Biol Med 38: 450-462, 2005.
118. Talman WT, Dragon DN. Transmission of arterial baroreflex signals depends on neuronal nitric oxide synthase. Hypertension 43: 820-824, 2004.
119. Talman WT. NO and central cardiovascular control: a simple molecule with a complex story. Hypertension 48: 552-554, 2006.
120. Tseng CJ, Liu HY, Lin HC, Ger LP, Tung CS, Yen MH. Cardiovascular effects of nitric oxide in the brain stem nuclei of rats. Hypertension 27: 36-42, 1996.
121. Waki H, Murphy D, Yao ST, Kasparov S, Paton JFR. Endothelial NO synthase activity in nucleus tractus solitarii contributes to hypertension in spontaneously hypertensive rats. Hypertension 48: 644-650, 2006.
122. Wang G, Anrather J, Huang J, Speth RC, Pickel VM, Iadecola C. NADPH oxidase contributes angiotensin signaling in the nucleus tractus solitarius. J Neurosci 24: 5516-5524, 2004.
123. 2+, and protein kinase C play a role in angiotensin II-induced free radical production in nucleus tractus solitarius. Hypertension 48: 482-489, 2006.
124. 1 receptor blockers. J Cardiovasc Pharmacol 41: 593-599, 2003.
125. Wang S, Paton JFR, Kasparov. Differential sensitivity of excitatory and inhibitory synaptic transmission to modulation by nitric oxide in rat nucleus tractus solitarii. Exp Physiol 92: 371-382, 2007.
126. Wu SY, Dun NJ. Potentiation of IPSCs by nitric oxide in immature rat sympathetic preganglionic neurons in vitro. J Physiol 495: 479-490, 1996.
127. Wu SY, Dun NJ. Nitric oxide and excitatory postsynaptic currents in immature rat sympathetic preganglionic neurons in vitro. Neuroscience 79: 237-245, 1997.
128. Yin JX, Yang RF, Li S, Renshaw AO, Li YL, Schultz HD, Zimmerman MC. Mitochondria-produced superoxide mediates angiotensin IIinduced inhibition of neuronal potassium current. Am J Physiol Cell Physiol 298: C857-C865, 2010.
129. Zanzinger J. Role of nitric oxide in the neural control of cardiovascular function. Cardiovasc Res 43: 639-649, 1999.
130. Zanzinger J. Mechanisms of action of nitric oxide in the brain stem: role of oxidative stress. Auton Neurosci 98: 24-27, 2002.
131. Zanzinger J, Czachurski J, Seller H. Inhibition of basal and reflexmediated sympathetic activity in the RVLM by nitric oxide. Am J Physiol Regul Integr Comp Physiol 268: R958-R962, 1995.
132. Zimmerman MC, Lazartigues E, Lang JA, Sinnayah P, Ahmad IM, Spitz DR, Davisson RL. Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res 91: 1038-1045, 2002.
133. Zimmerman MC, Lazartigues E, Sharma RV, Davisson RL. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res 95: 210-216, 2004.
134. Zimmerman MC, Dunlay RP, Larzartigues E, Zhang Y, Sharma RV, Engelhardt JF, Davisson RL. Requirement for Rac-1dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain. Circ Res 95: 532-539, 2004.
135. Zimmerman MC, Sharma RV, Davisson RL. Superoxide mediates angiotensin II-induced influx of extracellular calcium in neural cells. Hypertension 45: 717-723, 2005.
136. Zimmerman MC, Zucker IH. Mitochondrial dysfunction and mitochondrial-produced reactive oxygen species: new targets for neurogenic hypertension? Hypertension 53: 112-114, 2009.